Trial Outcomes & Findings for Effect of Daily Low Dose Aspirin on Exhaled Inflammatory Mediators in Normal Subjects (NCT NCT00898222)

Results Overview

Descriptive statistics

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

4 participants

Primary outcome timeframe

baseline and 6 months

Results posted on

2015-09-25

Participant milestones
Measure	Aspirin Low dose daily aspirin in healthy volunteers for two weeks aspirin : 81 mg orally daily for two weeks
Overall Study STARTED	4
Overall Study COMPLETED	4
Overall Study NOT COMPLETED	0

Withdrawal data not reported

Effect of Daily Low Dose Aspirin on Exhaled Inflammatory Mediators in Normal Subjects

Baseline characteristics by cohort
Measure	Aspirin n=4 Participants Low dose daily aspirin in healthy volunteers for two weeks aspirin : 81 mg orally daily for two weeks
Age, Categorical <=18 years	0 Participants n=93 Participants
Age, Categorical Between 18 and 65 years	4 Participants n=93 Participants
Age, Categorical >=65 years	0 Participants n=93 Participants
Age, Continuous	26 years STANDARD_DEVIATION 2.94 • n=93 Participants
Sex: Female, Male Female	2 Participants n=93 Participants
Sex: Female, Male Male	2 Participants n=93 Participants
Region of Enrollment United States	4 participants n=93 Participants

Timeframe: baseline and 6 months

Descriptive statistics

Outcome measures
Measure	Aspirin n=4 Participants Low dose daily aspirin in healthy volunteers for two weeks aspirin : 81 mg orally daily for two weeks
Change in Exhaled Inflammatory Mediator Levels	1.42 pg/mL Interval 0.23 to 1.98

Serious events: 0 serious events

Other events: 0 other events

Deaths: 0 deaths

Adverse event data not reported

Adverse event data not reported

Brigham and Women's Hospital

Phone: 617-732-8201